BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 2024 hits of ic50 data for polymerid = 5221,5224,8954   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Tyrosine-protein kinase ABL1


(Homo sapiens (Human))
BDBM50300027
PNG
((S)-1-Acryloyl-N-[4-(3-chloro-2,4-difluorophenylam...)
Show SMILES COCCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3F)c2cc1NC(=O)[C@@H]1CCCN1C(=O)C=C
Show InChI InChI=1S/C25H24ClF2N5O4/c1-3-21(34)33-8-4-5-19(33)25(35)32-18-11-14-17(12-20(18)37-10-9-36-2)29-13-30-24(14)31-16-7-6-15(27)22(26)23(16)28/h3,6-7,11-13,19H,1,4-5,8-10H2,2H3,(H,32,35)(H,29,30,31)/t19-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a<0.100n/an/an/an/an/an/a



Hanmi Research Center

Curated by ChEMBL


Assay Description
Inhibition of Abl1


J Med Chem 52: 6880-8 (2009)


Article DOI: 10.1021/jm901146p
BindingDB Entry DOI: 10.7270/Q28W3DDJ
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM230799
PNG
(US9340537, 53)
Show SMILES CN(C)[C@H]1CN(C[C@@H]1O)c1ncc(cc1-c1ccn[nH]1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C22H23ClF2N6O3/c1-30(2)18-11-31(12-19(18)32)20-16(17-7-8-27-29-17)9-13(10-26-20)21(33)28-14-3-5-15(6-4-14)34-22(23,24)25/h3-10,18-19,32H,11-12H2,1-2H3,(H,27,29)(H,28,33)/t18-,19-/m0/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.100n/an/an/an/a7.525



NOVATIS AG

US Patent


Assay Description
The assay was performed by mixing 10 μL of the compound pre-diluted with 10 μL of ATP (20 μM ATP with 0.1 μCi [γ-33P]-ATP) with the...


US Patent US9340537 (2016)


BindingDB Entry DOI: 10.7270/Q2FB51T5
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM230775
PNG
(US9340537, 29)
Show SMILES O[C@H]1CN(C[C@@H]1O)c1ccc(cc1-c1ccc([nH]1)C#N)C(=O)Nc1ccc(OC(F)(F)F)cc1
Show InChI InChI=1S/C23H19F3N4O4/c24-23(25,26)34-16-5-2-14(3-6-16)29-22(33)13-1-8-19(30-11-20(31)21(32)12-30)17(9-13)18-7-4-15(10-27)28-18/h1-9,20-21,28,31-32H,11-12H2,(H,29,33)/t20-,21-/m0/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.100n/an/an/an/a7.525



NOVATIS AG

US Patent


Assay Description
The assay was performed by mixing 10 μL of the compound pre-diluted with 10 μL of ATP (20 μM ATP with 0.1 μCi [γ-33P]-ATP) with the...


US Patent US9340537 (2016)


BindingDB Entry DOI: 10.7270/Q2FB51T5
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM230777
PNG
(US9340537, 31)
Show SMILES O[C@H]1CN(C[C@@H]1O)c1ncc(cc1-c1ccc([nH]1)C#N)C(=O)Nc1ccc(OC(F)(F)F)cc1
Show InChI InChI=1S/C22H18F3N5O4/c23-22(24,25)34-15-4-1-13(2-5-15)29-21(33)12-7-16(17-6-3-14(8-26)28-17)20(27-9-12)30-10-18(31)19(32)11-30/h1-7,9,18-19,28,31-32H,10-11H2,(H,29,33)/t18-,19-/m0/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.100n/an/an/an/a7.525



NOVATIS AG

US Patent


Assay Description
The assay was performed by mixing 10 μL of the compound pre-diluted with 10 μL of ATP (20 μM ATP with 0.1 μCi [γ-33P]-ATP) with the...


US Patent US9340537 (2016)


BindingDB Entry DOI: 10.7270/Q2FB51T5
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM230795
PNG
(US9340537, 49)
Show SMILES CC1(O)CCN(C1)c1ncc(cc1-c1ccn[nH]1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C21H20ClF2N5O3/c1-20(31)7-9-29(12-20)18-16(17-6-8-26-28-17)10-13(11-25-18)19(30)27-14-2-4-15(5-3-14)32-21(22,23)24/h2-6,8,10-11,31H,7,9,12H2,1H3,(H,26,28)(H,27,30)
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.100n/an/an/an/a7.525



NOVATIS AG

US Patent


Assay Description
The assay was performed by mixing 10 μL of the compound pre-diluted with 10 μL of ATP (20 μM ATP with 0.1 μCi [γ-33P]-ATP) with the...


US Patent US9340537 (2016)


BindingDB Entry DOI: 10.7270/Q2FB51T5
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213682
PNG
(US9278981, 274)
Show SMILES O[C@@H]1CCN(C1)c1ncc(cc1-c1cnccc1C#N)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C23H18ClF2N5O3/c24-23(25,26)34-18-3-1-16(2-4-18)30-22(33)15-9-19(20-12-28-7-5-14(20)10-27)21(29-11-15)31-8-6-17(32)13-31/h1-5,7,9,11-12,17,32H,6,8,13H2,(H,30,33)/t17-/m1/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.100n/an/an/an/a7.525



Novartis AG

US Patent


Assay Description
For determination of ABL kinase activity, the radiometric filter-binding assay was used. The assay was performed by mixing 10 uL of the compound pre-...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM230809
PNG
(US9340537, 63)
Show SMILES OC1CN(C1)c1ncc(cc1-c1ccn[nH]1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C19H16ClF2N5O3/c20-19(21,22)30-14-3-1-12(2-4-14)25-18(29)11-7-15(16-5-6-24-26-16)17(23-8-11)27-9-13(28)10-27/h1-8,13,28H,9-10H2,(H,24,26)(H,25,29)
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.100n/an/an/an/a7.525



NOVATIS AG

US Patent


Assay Description
The assay was performed by mixing 10 μL of the compound pre-diluted with 10 μL of ATP (20 μM ATP with 0.1 μCi [γ-33P]-ATP) with the...


US Patent US9340537 (2016)


BindingDB Entry DOI: 10.7270/Q2FB51T5
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213659
PNG
(US9278981, 251)
Show SMILES CN(C)[C@H]1CN(C[C@@H]1O)c1ncc(cc1-c1cncnc1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C23H23ClF2N6O3/c1-31(2)19-11-32(12-20(19)33)21-18(15-8-27-13-28-9-15)7-14(10-29-21)22(34)30-16-3-5-17(6-4-16)35-23(24,25)26/h3-10,13,19-20,33H,11-12H2,1-2H3,(H,30,34)/t19-,20-/m0/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.100n/an/an/an/a7.525



Novartis AG

US Patent


Assay Description
For determination of ABL kinase activity, the radiometric filter-binding assay was used. The assay was performed by mixing 10 uL of the compound pre-...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213662
PNG
(US9278981, 254)
Show SMILES FC(F)(Cl)Oc1ccc(NC(=O)c2cnc(N3Cc4cn[nH]c4C3)c(c2)-c2cncnc2)cc1
Show InChI InChI=1S/C22H16ClF2N7O2/c23-22(24,25)34-17-3-1-16(2-4-17)30-21(33)13-5-18(14-6-26-12-27-7-14)20(28-8-13)32-10-15-9-29-31-19(15)11-32/h1-9,12H,10-11H2,(H,29,31)(H,30,33)
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.100n/an/an/an/a7.525



Novartis AG

US Patent


Assay Description
For determination of ABL kinase activity, the radiometric filter-binding assay was used. The assay was performed by mixing 10 uL of the compound pre-...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213677
PNG
(US9278981, 269)
Show SMILES O[C@H]1CN(C[C@@H]1O)c1ncc(cc1-c1cncc(c1)C#N)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C23H18ClF2N5O4/c24-23(25,26)35-17-3-1-16(2-4-17)30-22(34)15-6-18(14-5-13(7-27)8-28-9-14)21(29-10-15)31-11-19(32)20(33)12-31/h1-6,8-10,19-20,32-33H,11-12H2,(H,30,34)/t19-,20-/m0/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.100n/an/an/an/a7.525



Novartis AG

US Patent


Assay Description
For determination of ABL kinase activity, the radiometric filter-binding assay was used. The assay was performed by mixing 10 uL of the compound pre-...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1


(Homo sapiens (Human))
BDBM223091
PNG
(2-(Dimethylamino)ethyl 4-(6-((5-((2-chloro-6-methy...)
Show SMILES CN(C)CCOC(=O)N1CCN(CC1)c1cc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)nc(C)n1
Show InChI InChI=1S/C25H31ClN8O3S/c1-16-6-5-7-18(26)22(16)31-23(35)19-15-27-24(38-19)30-20-14-21(29-17(2)28-20)33-8-10-34(11-9-33)25(36)37-13-12-32(3)4/h5-7,14-15H,8-13H2,1-4H3,(H,31,35)(H,27,28,29,30)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.105n/an/an/an/a7.525



Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences



Assay Description
ABL activity assays were performed in 384-well plate using the FRET-based Z'-Lyteassay system and Tyr-2 peptide substrate according to the manufa...


Chem Biol Drug Des 89: 420-427 (2017)


Article DOI: 10.1111/cbdd.12863
BindingDB Entry DOI: 10.7270/Q29C6W98
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM230768
PNG
(US9340537, 22)
Show SMILES O[C@@H]1CCN(C1)c1ncc(cc1-c1ccc[nH]1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C21H19ClF2N4O3/c22-21(23,24)31-16-5-3-14(4-6-16)27-20(30)13-10-17(18-2-1-8-25-18)19(26-11-13)28-9-7-15(29)12-28/h1-6,8,10-11,15,25,29H,7,9,12H2,(H,27,30)/t15-/m1/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.130n/an/an/an/a7.530



NOVATIS AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9340537 (2016)


BindingDB Entry DOI: 10.7270/Q2FB51T5
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213581
PNG
(US9278981, 173)
Show SMILES O[C@@H]1CCN(C1)c1ncc(cc1-c1cncc(c1)C#N)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C23H18ClF2N5O3/c24-23(25,26)34-19-3-1-17(2-4-19)30-22(33)16-8-20(15-7-14(9-27)10-28-11-15)21(29-12-16)31-6-5-18(32)13-31/h1-4,7-8,10-12,18,32H,5-6,13H2,(H,30,33)/t18-/m1/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.130n/an/an/an/a7.530



Novartis AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM230814
PNG
(US9340537, 68)
Show SMILES FC(F)(Cl)Oc1ccc(NC(=O)c2cnc(N3CC4(CNC4)C3)c(c2)-c2ccn[nH]2)cc1
Show InChI InChI=1S/C21H19ClF2N6O2/c22-21(23,24)32-15-3-1-14(2-4-15)28-19(31)13-7-16(17-5-6-27-29-17)18(26-8-13)30-11-20(12-30)9-25-10-20/h1-8,25H,9-12H2,(H,27,29)(H,28,31)
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.130n/an/an/an/a7.530



NOVATIS AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9340537 (2016)


BindingDB Entry DOI: 10.7270/Q2FB51T5
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM230826
PNG
(US9340537, 80)
Show SMILES NC[C@H]1CN(C[C@H]1O)c1ncc(cc1-c1ccn[nH]1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C21H21ClF2N6O3/c22-21(23,24)33-15-3-1-14(2-4-15)28-20(32)12-7-16(17-5-6-27-29-17)19(26-9-12)30-10-13(8-25)18(31)11-30/h1-7,9,13,18,31H,8,10-11,25H2,(H,27,29)(H,28,32)/t13-,18+/m0/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.130n/an/an/an/a7.530



NOVATIS AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9340537 (2016)


BindingDB Entry DOI: 10.7270/Q2FB51T5
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213603
PNG
(US9278981, 195)
Show SMILES CCN(CCO)c1ncc(cc1-c1cncnc1)C(=O)Nc1ccc(SC(F)(F)F)cc1
Show InChI InChI=1S/C21H20F3N5O2S/c1-2-29(7-8-30)19-18(15-10-25-13-26-11-15)9-14(12-27-19)20(31)28-16-3-5-17(6-4-16)32-21(22,23)24/h3-6,9-13,30H,2,7-8H2,1H3,(H,28,31)
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.130n/an/an/an/a7.530



Novartis AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213613
PNG
(US9278981, 205)
Show SMILES O[C@@H]1CCN(C1)c1ncc(cc1-c1cncnc1)C(=O)Nc1ccc(SC(F)(F)F)c(F)c1
Show InChI InChI=1S/C21H17F4N5O2S/c22-17-6-14(1-2-18(17)33-21(23,24)25)29-20(32)12-5-16(13-7-26-11-27-8-13)19(28-9-12)30-4-3-15(31)10-30/h1-2,5-9,11,15,31H,3-4,10H2,(H,29,32)/t15-/m1/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.130n/an/an/an/a7.530



Novartis AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213655
PNG
(US9278981, 247)
Show SMILES FC(F)(Cl)Oc1ccc(NC(=O)c2cnc(N3CCC(F)(F)C3)c(c2)-c2cncnc2)cc1
Show InChI InChI=1S/C21H16ClF4N5O2/c22-21(25,26)33-16-3-1-15(2-4-16)30-19(32)13-7-17(14-8-27-12-28-9-14)18(29-10-13)31-6-5-20(23,24)11-31/h1-4,7-10,12H,5-6,11H2,(H,30,32)
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.130n/an/an/an/a7.530



Novartis AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213656
PNG
(US9278981, 248)
Show SMILES O[C@H]1CN(C[C@@H]1O)c1ncc(cc1-c1cncnc1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C21H18ClF2N5O4/c22-21(23,24)33-15-3-1-14(2-4-15)28-20(32)12-5-16(13-6-25-11-26-7-13)19(27-8-12)29-9-17(30)18(31)10-29/h1-8,11,17-18,30-31H,9-10H2,(H,28,32)/t17-,18-/m0/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.130n/an/an/an/a7.530



Novartis AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213667
PNG
(US9278981, 259)
Show SMILES NC1CN(C1)c1ncc(cc1-c1cncnc1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C20H17ClF2N6O2/c21-20(22,23)31-16-3-1-15(2-4-16)28-19(30)12-5-17(13-6-25-11-26-7-13)18(27-8-12)29-9-14(24)10-29/h1-8,11,14H,9-10,24H2,(H,28,30)
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.130n/an/an/an/a7.530



Novartis AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213671
PNG
(US9278981, 263)
Show SMILES Cc1ncncc1-c1cc(cnc1N1CC[C@@H](O)C1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C22H20ClF2N5O3/c1-13-19(10-26-12-28-13)18-8-14(9-27-20(18)30-7-6-16(31)11-30)21(32)29-15-2-4-17(5-3-15)33-22(23,24)25/h2-5,8-10,12,16,31H,6-7,11H2,1H3,(H,29,32)/t16-/m1/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.130n/an/an/an/a7.530



Novartis AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213673
PNG
(US9278981, 265)
Show SMILES O[C@H]1CN(C[C@@H]1O)c1ncc(cc1-c1cncc(F)c1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C22H18ClF3N4O4/c23-22(25,26)34-16-3-1-15(2-4-16)29-21(33)13-6-17(12-5-14(24)9-27-7-12)20(28-8-13)30-10-18(31)19(32)11-30/h1-9,18-19,31-32H,10-11H2,(H,29,33)/t18-,19-/m0/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.130n/an/an/an/a7.530



Novartis AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213677
PNG
(US9278981, 269)
Show SMILES O[C@H]1CN(C[C@@H]1O)c1ncc(cc1-c1cncc(c1)C#N)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C23H18ClF2N5O4/c24-23(25,26)35-17-3-1-16(2-4-17)30-22(34)15-6-18(14-5-13(7-27)8-28-9-14)21(29-10-15)31-11-19(32)20(33)12-31/h1-6,8-10,19-20,32-33H,11-12H2,(H,30,34)/t19-,20-/m0/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.130n/an/an/an/a7.530



Novartis AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM230777
PNG
(US9340537, 31)
Show SMILES O[C@H]1CN(C[C@@H]1O)c1ncc(cc1-c1ccc([nH]1)C#N)C(=O)Nc1ccc(OC(F)(F)F)cc1
Show InChI InChI=1S/C22H18F3N5O4/c23-22(24,25)34-15-4-1-13(2-5-15)29-21(33)12-7-16(17-6-3-14(8-26)28-17)20(27-9-12)30-10-18(31)19(32)11-30/h1-7,9,18-19,28,31-32H,10-11H2,(H,29,33)/t18-,19-/m0/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.130n/an/an/an/a7.530



NOVATIS AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9340537 (2016)


BindingDB Entry DOI: 10.7270/Q2FB51T5
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213496
PNG
(US9278981, 88)
Show SMILES OC[C@H]1CCN(C1)c1ncc(cc1-c1ccc(Cl)nc1)C(=O)Nc1ccc(OC(F)(F)F)cc1
Show InChI InChI=1S/C23H20ClF3N4O3/c24-20-6-1-15(10-28-20)19-9-16(11-29-21(19)31-8-7-14(12-31)13-32)22(33)30-17-2-4-18(5-3-17)34-23(25,26)27/h1-6,9-11,14,32H,7-8,12-13H2,(H,30,33)/t14-/m0/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.130n/an/an/an/a7.530



Novartis AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213559
PNG
(US9278981, 151)
Show SMILES CN(CCO)c1ncc(cc1-c1cncnc1)C(=O)Nc1ccc(OC(F)(F)F)cc1
Show InChI InChI=1S/C20H18F3N5O3/c1-28(6-7-29)18-17(14-9-24-12-25-10-14)8-13(11-26-18)19(30)27-15-2-4-16(5-3-15)31-20(21,22)23/h2-5,8-12,29H,6-7H2,1H3,(H,27,30)
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.130n/an/an/an/a7.530



Novartis AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213578
PNG
(US9278981, 170)
Show SMILES O[C@@H]1CCN(C1)c1ncc(cc1-c1cncnc1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C21H18ClF2N5O3/c22-21(23,24)32-17-3-1-15(2-4-17)28-20(31)13-7-18(14-8-25-12-26-9-14)19(27-10-13)29-6-5-16(30)11-29/h1-4,7-10,12,16,30H,5-6,11H2,(H,28,31)/t16-/m1/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.130n/an/an/an/a7.530



Novartis AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213579
PNG
(US9278981, 171)
Show SMILES O[C@@H]1CCN(C1)c1ncc(cc1-c1cncc(F)c1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C22H18ClF3N4O3/c23-22(25,26)33-18-3-1-16(2-4-18)29-21(32)14-8-19(13-7-15(24)11-27-9-13)20(28-10-14)30-6-5-17(31)12-30/h1-4,7-11,17,31H,5-6,12H2,(H,29,32)/t17-/m1/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a<0.130n/an/an/an/a7.530



Novartis AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1


(Homo sapiens (Human))
BDBM13216
PNG
(BMS-354825 | CHEMBL1421 | DASATINIB | N-(2-Chloro-...)
Show SMILES Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CCO)CC1
Show InChI InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
Purchase

CHEMBL
DrugBank
MMDB
PC cid
PC sid
PDB
UniChem

Patents


Similars

PDB
Article
PubMed
n/an/a 0.138n/an/an/an/a7.525



Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences



Assay Description
ABL activity assays were performed in 384-well plate using the FRET-based Z'-Lyteassay system and Tyr-2 peptide substrate according to the manufa...


Chem Biol Drug Des 89: 420-427 (2017)


Article DOI: 10.1111/cbdd.12863
BindingDB Entry DOI: 10.7270/Q29C6W98
More data for this
Ligand-Target Pair
3D
3D Structure (crystal)
Tyrosine-protein kinase ABL1


(Homo sapiens (Human))
BDBM223081
PNG
(Methyl 4-(6-((5-((2-chloro-6-methylphenyl)carbamoy...)
Show SMILES COC(=O)N1CCN(CC1)c1cc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)nc(C)n1
Show InChI InChI=1S/C22H24ClN7O3S/c1-13-5-4-6-15(23)19(13)28-20(31)16-12-24-21(34-16)27-17-11-18(26-14(2)25-17)29-7-9-30(10-8-29)22(32)33-3/h4-6,11-12H,7-10H2,1-3H3,(H,28,31)(H,24,25,26,27)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.152n/an/an/an/a7.525



Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences



Assay Description
ABL activity assays were performed in 384-well plate using the FRET-based Z'-Lyteassay system and Tyr-2 peptide substrate according to the manufa...


Chem Biol Drug Des 89: 420-427 (2017)


Article DOI: 10.1111/cbdd.12863
BindingDB Entry DOI: 10.7270/Q29C6W98
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1


(Homo sapiens (Human))
BDBM223082
PNG
(Ethyl 4-(6-((5-((2-chloro-6-methylphenyl)carbamoyl...)
Show SMILES CCOC(=O)N1CCN(CC1)c1cc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)nc(C)n1
Show InChI InChI=1S/C23H26ClN7O3S/c1-4-34-23(33)31-10-8-30(9-11-31)19-12-18(26-15(3)27-19)28-22-25-13-17(35-22)21(32)29-20-14(2)6-5-7-16(20)24/h5-7,12-13H,4,8-11H2,1-3H3,(H,29,32)(H,25,26,27,28)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.175n/an/an/an/a7.525



Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences



Assay Description
ABL activity assays were performed in 384-well plate using the FRET-based Z'-Lyteassay system and Tyr-2 peptide substrate according to the manufa...


Chem Biol Drug Des 89: 420-427 (2017)


Article DOI: 10.1111/cbdd.12863
BindingDB Entry DOI: 10.7270/Q29C6W98
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1


(Homo sapiens (Human))
BDBM223092
PNG
(2-((6-(4-Acryloylpiperazin-1-yl)-2-methylpyrimidin...)
Show SMILES Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CC1)C(=O)C=C
Show InChI InChI=1S/C23H24ClN7O2S/c1-4-20(32)31-10-8-30(9-11-31)19-12-18(26-15(3)27-19)28-23-25-13-17(34-23)22(33)29-21-14(2)6-5-7-16(21)24/h4-7,12-13H,1,8-11H2,2-3H3,(H,29,33)(H,25,26,27,28)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.178n/an/an/an/a7.525



Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences



Assay Description
ABL activity assays were performed in 384-well plate using the FRET-based Z'-Lyteassay system and Tyr-2 peptide substrate according to the manufa...


Chem Biol Drug Des 89: 420-427 (2017)


Article DOI: 10.1111/cbdd.12863
BindingDB Entry DOI: 10.7270/Q29C6W98
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1


(Homo sapiens (Human))
BDBM223090
PNG
(2-Morpholinoethyl 4-(6-((5-((2-chloro-6-methylphen...)
Show SMILES Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)N1CCN(CC1)C(=O)OCCN1CCOCC1
Show InChI InChI=1S/C27H33ClN8O4S/c1-18-4-3-5-20(28)24(18)33-25(37)21-17-29-26(41-21)32-22-16-23(31-19(2)30-22)35-6-8-36(9-7-35)27(38)40-15-12-34-10-13-39-14-11-34/h3-5,16-17H,6-15H2,1-2H3,(H,33,37)(H,29,30,31,32)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.179n/an/an/an/a7.525



Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences



Assay Description
ABL activity assays were performed in 384-well plate using the FRET-based Z'-Lyteassay system and Tyr-2 peptide substrate according to the manufa...


Chem Biol Drug Des 89: 420-427 (2017)


Article DOI: 10.1111/cbdd.12863
BindingDB Entry DOI: 10.7270/Q29C6W98
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1


(Homo sapiens (Human))
BDBM223093
PNG
((E)-2-((6-(4-(but-2-enoyl)piperazin-1-yl)-2-methyl...)
Show SMILES C\C=C\C(=O)N1CCN(CC1)c1cc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)nc(C)n1
Show InChI InChI=1S/C24H26ClN7O2S/c1-4-6-21(33)32-11-9-31(10-12-32)20-13-19(27-16(3)28-20)29-24-26-14-18(35-24)23(34)30-22-15(2)7-5-8-17(22)25/h4-8,13-14H,9-12H2,1-3H3,(H,30,34)(H,26,27,28,29)/b6-4+
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.191n/an/an/an/a7.525



Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences



Assay Description
ABL activity assays were performed in 384-well plate using the FRET-based Z'-Lyteassay system and Tyr-2 peptide substrate according to the manufa...


Chem Biol Drug Des 89: 420-427 (2017)


Article DOI: 10.1111/cbdd.12863
BindingDB Entry DOI: 10.7270/Q29C6W98
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1


(Homo sapiens (Human))
BDBM223097
PNG
(Allyl 3-(6-((5-((2-chloro-6-methylphenyl)carbamoyl...)
Show SMILES Cc1nc(Nc2ncc(s2)C(=O)Nc2c(C)cccc2Cl)cc(n1)C1CCN(C1)C(=O)OCC=C
Show InChI InChI=1S/C24H25ClN6O3S/c1-4-10-34-24(33)31-9-8-16(13-31)18-11-20(28-15(3)27-18)29-23-26-12-19(35-23)22(32)30-21-14(2)6-5-7-17(21)25/h4-7,11-12,16H,1,8-10,13H2,2-3H3,(H,30,32)(H,26,27,28,29)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 0.198n/an/an/an/a7.525



Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences



Assay Description
ABL activity assays were performed in 384-well plate using the FRET-based Z'-Lyteassay system and Tyr-2 peptide substrate according to the manufa...


Chem Biol Drug Des 89: 420-427 (2017)


Article DOI: 10.1111/cbdd.12863
BindingDB Entry DOI: 10.7270/Q29C6W98
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1


(Homo sapiens (Human))
BDBM50345579
PNG
(5-((5-(4-((4-(2-hydroxyethyl)piperazin-1-yl)methyl...)
Show SMILES CNC(=O)c1ncc(C#Cc2cc(ccc2C)C(=O)Nc2ccc(CN3CCN(CCO)CC3)c(c2)C(F)(F)F)n1C
Show InChI InChI=1S/C30H33F3N6O3/c1-20-4-5-22(16-21(20)7-9-25-18-35-27(37(25)3)29(42)34-2)28(41)36-24-8-6-23(26(17-24)30(31,32)33)19-39-12-10-38(11-13-39)14-15-40/h4-6,8,16-18,40H,10-15,19H2,1-3H3,(H,34,42)(H,36,41)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 0.200n/an/an/an/an/an/a



ARIAD Pharmaceuticals, Inc.

Curated by ChEMBL


Assay Description
Inhibition of wild type human ABL using [EAIYAAPFAKKK] peptide substrate by Hotspot assay


Bioorg Med Chem Lett 21: 3743-8 (2011)


Article DOI: 10.1016/j.bmcl.2011.04.060
BindingDB Entry DOI: 10.7270/Q21G0MM8
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213589
PNG
(US9278981, 181)
Show SMILES CN(CCO)c1ncc(cc1-c1cncc(c1)C#N)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C22H18ClF2N5O3/c1-30(6-7-31)20-19(15-8-14(10-26)11-27-12-15)9-16(13-28-20)21(32)29-17-2-4-18(5-3-17)33-22(23,24)25/h2-5,8-9,11-13,31H,6-7H2,1H3,(H,29,32)
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 0.200n/an/an/an/a7.530



Novartis AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1


(Homo sapiens (Human))
BDBM50427749
PNG
(CHEMBL2324924)
Show SMILES CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cncc4nccn34)cc2C(F)(F)F)CC1
Show InChI InChI=1S/C29H27F3N6O/c1-20-3-4-22(15-21(20)6-8-25-17-33-18-27-34-9-10-38(25)27)28(39)35-24-7-5-23(26(16-24)29(30,31)32)19-37-13-11-36(2)12-14-37/h3-5,7,9-10,15-18H,11-14,19H2,1-2H3,(H,35,39)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 0.200n/an/an/an/an/an/a



Cyclofluidic Ltd

Curated by ChEMBL


Assay Description
Inhibition of Abl1 kinase (unknown origin) using Tyr 6 peptide as substrate assessed as residual enzyme activity after every 10 secs measured for 10 ...


J Med Chem 56: 3033-47 (2013)


Article DOI: 10.1021/jm400099d
BindingDB Entry DOI: 10.7270/Q24T6KPD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213583
PNG
(US9278981, 175)
Show SMILES OC[C@H]1CCN(C1)c1ncc(cc1-c1cncc(F)c1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C23H20ClF3N4O3/c24-23(26,27)34-19-3-1-18(2-4-19)30-22(33)16-8-20(15-7-17(25)11-28-9-15)21(29-10-16)31-6-5-14(12-31)13-32/h1-4,7-11,14,32H,5-6,12-13H2,(H,30,33)/t14-/m0/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 0.200n/an/an/an/a7.530



Novartis AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM230815
PNG
(US9340537, 69)
Show SMILES CC1(O)CN(C1)c1ncc(cc1-c1ncc[nH]1)C(=O)Nc1ccc(OC(F)(F)F)cc1
Show InChI InChI=1S/C20H18F3N5O3/c1-19(30)10-28(11-19)17-15(16-24-6-7-25-16)8-12(9-26-17)18(29)27-13-2-4-14(5-3-13)31-20(21,22)23/h2-9,30H,10-11H2,1H3,(H,24,25)(H,27,29)
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 0.200n/an/an/an/a7.525



NOVATIS AG

US Patent


Assay Description
The assay was performed by mixing 10 μL of the compound pre-diluted with 10 μL of ATP (20 μM ATP with 0.1 μCi [γ-33P]-ATP) with the...


US Patent US9340537 (2016)


BindingDB Entry DOI: 10.7270/Q2FB51T5
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM230801
PNG
(US9340537, 55)
Show SMILES N[C@H]1[C@@H]2CN(C[C@H]12)c1ncc(cc1-c1ccn[nH]1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C21H19ClF2N6O2/c22-21(23,24)32-13-3-1-12(2-4-13)28-20(31)11-7-14(17-5-6-27-29-17)19(26-8-11)30-9-15-16(10-30)18(15)25/h1-8,15-16,18H,9-10,25H2,(H,27,29)(H,28,31)/t15-,16+,18+
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 0.200n/an/an/an/a7.530



NOVATIS AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9340537 (2016)


BindingDB Entry DOI: 10.7270/Q2FB51T5
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM230810
PNG
(US9340537, 64)
Show SMILES NC1CN(C1)c1ncc(cc1-c1ccn[nH]1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C19H17ClF2N6O2/c20-19(21,22)30-14-3-1-13(2-4-14)26-18(29)11-7-15(16-5-6-25-27-16)17(24-8-11)28-9-12(23)10-28/h1-8,12H,9-10,23H2,(H,25,27)(H,26,29)
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 0.200n/an/an/an/a7.530



NOVATIS AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9340537 (2016)


BindingDB Entry DOI: 10.7270/Q2FB51T5
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM230815
PNG
(US9340537, 69)
Show SMILES CC1(O)CN(C1)c1ncc(cc1-c1ncc[nH]1)C(=O)Nc1ccc(OC(F)(F)F)cc1
Show InChI InChI=1S/C20H18F3N5O3/c1-19(30)10-28(11-19)17-15(16-24-6-7-25-16)8-12(9-26-17)18(29)27-13-2-4-14(5-3-13)31-20(21,22)23/h2-9,30H,10-11H2,1H3,(H,24,25)(H,27,29)
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 0.200n/an/an/an/a7.530



NOVATIS AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9340537 (2016)


BindingDB Entry DOI: 10.7270/Q2FB51T5
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM230834
PNG
(US9340537, 88)
Show SMILES OC1CN(C1)c1ncc(cc1-c1[nH]ncc1F)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C19H15ClF3N5O3/c20-19(22,23)31-13-3-1-11(2-4-13)26-18(30)10-5-14(16-15(21)7-25-27-16)17(24-6-10)28-8-12(29)9-28/h1-7,12,29H,8-9H2,(H,25,27)(H,26,30)
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 0.200n/an/an/an/a7.530



NOVATIS AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9340537 (2016)


BindingDB Entry DOI: 10.7270/Q2FB51T5
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM230835
PNG
(US9340537, 89)
Show SMILES Cc1cc([nH]n1)-c1cc(cnc1N1CC(O)C1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C20H18ClF2N5O3/c1-11-6-17(27-26-11)16-7-12(8-24-18(16)28-9-14(29)10-28)19(30)25-13-2-4-15(5-3-13)31-20(21,22)23/h2-8,14,29H,9-10H2,1H3,(H,25,30)(H,26,27)
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 0.200n/an/an/an/a7.530



NOVATIS AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9340537 (2016)


BindingDB Entry DOI: 10.7270/Q2FB51T5
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213593
PNG
(US9278981, 185)
Show SMILES O[C@H]1CCN(C1)c1ncc(cc1-c1cncnc1)C(=O)Nc1ccc(SC(F)(F)F)cc1
Show InChI InChI=1S/C21H18F3N5O2S/c22-21(23,24)32-17-3-1-15(2-4-17)28-20(31)13-7-18(14-8-25-12-26-9-14)19(27-10-13)29-6-5-16(30)11-29/h1-4,7-10,12,16,30H,5-6,11H2,(H,28,31)/t16-/m0/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 0.200n/an/an/an/a7.530



Novartis AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213594
PNG
(US9278981, 186)
Show SMILES O[C@@H]1CCN(C1)c1ncc(cc1-c1cncnc1)C(=O)Nc1ccc(SC(F)(F)F)cc1
Show InChI InChI=1S/C21H18F3N5O2S/c22-21(23,24)32-17-3-1-15(2-4-17)28-20(31)13-7-18(14-8-25-12-26-9-14)19(27-10-13)29-6-5-16(30)11-29/h1-4,7-10,12,16,30H,5-6,11H2,(H,28,31)/t16-/m1/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 0.200n/an/an/an/a7.530



Novartis AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213595
PNG
(US9278981, 187)
Show SMILES O[C@@H]1CCN(C1)c1ncc(cc1-c1cncc(F)c1)C(=O)Nc1ccc(SC(F)(F)F)cc1
Show InChI InChI=1S/C22H18F4N4O2S/c23-15-7-13(9-27-11-15)19-8-14(10-28-20(19)30-6-5-17(31)12-30)21(32)29-16-1-3-18(4-2-16)33-22(24,25)26/h1-4,7-11,17,31H,5-6,12H2,(H,29,32)/t17-/m1/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 0.200n/an/an/an/a7.530



Novartis AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213596
PNG
(US9278981, 188)
Show SMILES O[C@@H]1CCN(C1)c1ncc(cc1-c1cncc(c1)C#N)C(=O)Nc1ccc(SC(F)(F)F)cc1
Show InChI InChI=1S/C23H18F3N5O2S/c24-23(25,26)34-19-3-1-17(2-4-19)30-22(33)16-8-20(15-7-14(9-27)10-28-11-15)21(29-12-16)31-6-5-18(32)13-31/h1-4,7-8,10-12,18,32H,5-6,13H2,(H,30,33)/t18-/m1/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 0.200n/an/an/an/a7.530



Novartis AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Tyrosine-protein kinase ABL1 (ABL1)


(Homo sapiens (Human))
BDBM213699
PNG
(US9278981, 291)
Show SMILES Cc1ccncc1-c1cc(cnc1N1CC[C@@H](O)C1)C(=O)Nc1ccc(OC(F)(F)Cl)cc1
Show InChI InChI=1S/C23H21ClF2N4O3/c1-14-6-8-27-12-20(14)19-10-15(11-28-21(19)30-9-7-17(31)13-30)22(32)29-16-2-4-18(5-3-16)33-23(24,25)26/h2-6,8,10-12,17,31H,7,9,13H2,1H3,(H,29,32)/t17-/m1/s1
PDB

GoogleScholar
PC cid
PC sid
UniChem
US Patent
n/an/a 0.200n/an/an/an/a7.530



Novartis AG

US Patent


Assay Description
The assay plates were prepared by addition of 50 nL per well of compound solution in 90% DMSO. The kinase reactions were started by stepwise addition...


US Patent US9278981 (2016)


BindingDB Entry DOI: 10.7270/Q2DV1HRD
More data for this
Ligand-Target Pair
Displayed 1 to 50 (of 2024 total )  |  Next  |  Last  >>
Jump to: